Name | Number of supported studies | Average coverage | |
---|---|---|---|
enterocyte | 5 studies | 24% ± 5% |
Insufficient scRNA-seq data for expression of C1QTNF12 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 99% | 240.55 | 960 / 966 | 91% | 6.64 | 480 / 527 |
esophagus | 97% | 64.70 | 1404 / 1445 | 91% | 10.99 | 166 / 183 |
thymus | 99% | 60.44 | 644 / 653 | 84% | 9.83 | 511 / 605 |
ovary | 95% | 42.00 | 171 / 180 | 88% | 5.64 | 377 / 430 |
kidney | 100% | 229.25 | 89 / 89 | 81% | 4.55 | 730 / 901 |
bladder | 100% | 53.38 | 21 / 21 | 77% | 5.18 | 390 / 504 |
stomach | 91% | 45.67 | 325 / 359 | 85% | 6.74 | 242 / 286 |
uterus | 98% | 46.29 | 167 / 170 | 74% | 5.28 | 340 / 459 |
lung | 97% | 70.53 | 559 / 578 | 73% | 6.84 | 843 / 1155 |
brain | 87% | 40.42 | 2292 / 2642 | 64% | 1.50 | 454 / 705 |
breast | 99% | 81.75 | 456 / 459 | 40% | 1.31 | 446 / 1118 |
pancreas | 48% | 13.52 | 157 / 328 | 89% | 6.59 | 159 / 178 |
skin | 98% | 217.22 | 1778 / 1809 | 33% | 1.33 | 157 / 472 |
prostate | 96% | 51.90 | 234 / 245 | 35% | 0.57 | 174 / 502 |
liver | 92% | 46.75 | 209 / 226 | 32% | 1.32 | 128 / 406 |
adrenal gland | 69% | 20.57 | 177 / 258 | 33% | 0.62 | 76 / 230 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.25 | 1 / 1 |
adipose | 98% | 81.28 | 1179 / 1204 | 0% | 0 | 0 / 0 |
spleen | 95% | 44.46 | 230 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 94% | 50.14 | 1253 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 77% | 32.39 | 716 / 929 | 0% | 0 | 0 / 0 |
heart | 74% | 30.36 | 639 / 861 | 0% | 0 | 0 / 0 |
muscle | 64% | 21.34 | 513 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 62% | 7.18 | 28 / 45 |
eye | 0% | 0 | 0 / 0 | 57% | 1.97 | 46 / 80 |
lymph node | 0% | 0 | 0 / 0 | 48% | 0.68 | 14 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0050728 | Biological process | negative regulation of inflammatory response |
GO_0046323 | Biological process | glucose import |
GO_0046326 | Biological process | positive regulation of glucose import |
GO_0006094 | Biological process | gluconeogenesis |
GO_0045721 | Biological process | negative regulation of gluconeogenesis |
GO_0051649 | Biological process | establishment of localization in cell |
GO_0046324 | Biological process | regulation of glucose import |
GO_0043491 | Biological process | phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0046628 | Biological process | positive regulation of insulin receptor signaling pathway |
GO_0035774 | Biological process | positive regulation of insulin secretion involved in cellular response to glucose stimulus |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005179 | Molecular function | hormone activity |
Gene name | C1QTNF12 |
Protein name | Adipolin (Adipose-derived insulin-sensitizing factor) (C1q and TNF related protein 12) (Complement C1q tumor necrosis factor-related protein 12) [Cleaved into: Adipolin fC1QTNF12 (Adipolin fCTRP12) (Adipolin full-length form); Adipolin gC1QTNF12 (Adipolin cleaved form) (Adipolin gCTRP12)] |
Synonyms | FAM132A CTRP12 C1QDC2 |
Description | FUNCTION: Insulin-sensitizing adipocyte-secreted protein (adipokine) that regulates glucose metabolism in liver and adipose tissue. Promotes glucose uptake in adipocytes and suppresses de novo glucose production in hepatocytes via the PI3K-Akt signaling pathway. Administration lead to reduction of blood glucose. Able to attenuate inflammation in fat tissue. . |
Accessions | ENST00000330388.2 Q5T7M4 |